Dynamics of tumor progression and therapy response in Il-6 and Myc driven plasma cell malignancy
Emerging evidence indicates that 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are useful imaging modalities for evaluating tumor progression in transgenic mouse models of solid human cancers, but the potential of integrated FDG-PET/CT for assessing tumor...
Main Author: | Duncan, Kaylia Mekelda |
---|---|
Other Authors: | Janz, Siegfried |
Format: | Others |
Language: | English |
Published: |
University of Iowa
2013
|
Subjects: | |
Online Access: | https://ir.uiowa.edu/etd/4619 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=5135&context=etd |
Similar Items
-
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
by: Andrew L Hong, et al.
Published: (2019-03-01) -
A New Perspective for Osteosarcoma Therapy: Proteasome Inhibition by MLN9708/2238 Successfully Induces Apoptosis and Cell Cycle Arrest and Attenuates the Invasion Ability of Osteosarcoma Cells in Vitro
by: Renhao Liu, et al.
Published: (2017-01-01) -
Interest of Pet Imaging in Multiple Myeloma
by: Bastien Jamet, et al.
Published: (2019-04-01) -
PET-FDG: Impetus
by: Cristina Nanni
Published: (2020-04-01) -
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials
by: Anne-Victoire Michaud-Robert, et al.
Published: (2020-09-01)